4//SEC Filing
Brown Regina 4
Accession 0001493152-25-003183
CIK 0001335105other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 1:15 PM ET
Size
14.1 KB
Accession
0001493152-25-003183
Insider Transaction Report
Form 4
Brown Regina
Director
Transactions
- Award
Options to Purchase Common Stock
2025-01-20+4,924→ 4,924 totalExercise: $2.33From: 2025-01-20Exp: 2030-01-20→ Common (4,924 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $7.45From: 2022-06-30Exp: 2027-06-30→ Common (10,000 underlying) - 6,269
Options to Purchase Common Stock
Exercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (6,269 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $5.88From: 2023-06-30Exp: 2028-06-30→ Common (10,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $30.30From: 2021-06-30Exp: 2026-06-30→ Common (10,000 underlying) - 4,904
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (4,904 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $28.00From: 2021-05-11Exp: 2026-05-11→ Common (25,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying)
Footnotes (1)
- [F1]Effective January 20, 2025, the reporting person was granted stock options to purchase an aggregate of 4,924 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001862089
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 1:15 PM ET
- Size
- 14.1 KB